These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7230840)
1. Simultaneous radioenzymatic assay of dopamine and dihydroxyphenylacetic acid: an index of in vivo dopamine release. Cheng CH; Wooten GF J Pharmacol Methods; 1981 Mar; 5(2):165-73. PubMed ID: 7230840 [TBL] [Abstract][Full Text] [Related]
2. A radioenzymatic method to measure picogram amounts of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in small samples of brain tissue. Argiolas A; Fadda F Experientia; 1978 Jun; 34(6):739-41. PubMed ID: 658286 [TBL] [Abstract][Full Text] [Related]
3. [A rapid radioenzyme method for determining dopamine and 3,4-dihydroxyphenylacetic acid in the basal ganglia of the rat brain]. Petrenko SV; Markova SV; Gomolko NN Farmakol Toksikol; 1989; 52(2):94-7. PubMed ID: 2568274 [TBL] [Abstract][Full Text] [Related]
4. Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolites. Cheng CH; Wooten GF J Pharmacol Methods; 1982 Sep; 8(2):123-33. PubMed ID: 7144209 [TBL] [Abstract][Full Text] [Related]
5. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Zetterström T; Sharp T; Collin AK; Ungerstedt U Eur J Pharmacol; 1988 Apr; 148(3):327-34. PubMed ID: 3384000 [TBL] [Abstract][Full Text] [Related]
6. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats. Chen YF; Jin HK; Gist R; Oparil S Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616 [TBL] [Abstract][Full Text] [Related]
7. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of drugs on dopamine metabolism in the rat superior cervical ganglion by HPLC with electrochemical detection. Westerink BH; Van Oene JC Eur J Pharmacol; 1980 Jul; 65(1):71-9. PubMed ID: 7398778 [TBL] [Abstract][Full Text] [Related]
9. Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions. Watanabe H Life Sci; 1985 Dec; 37(24):2319-25. PubMed ID: 4068904 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous radioenzymatic assay of catecholamines and dihydroxy-phenylacetic acid /DOPAC/; comparison of the effects of drugs on the tuberoinfundibular and striatal dopamine metabolism and on plasma prolactin level. Fekete MI; Kanyicska B; Herman JP Life Sci; 1978 Oct; 23(15):1549-56. PubMed ID: 31526 [No Abstract] [Full Text] [Related]
11. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
12. A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid. Saller CF; Zigmond MJ Life Sci; 1978 Sep; 23(11):1117-30. PubMed ID: 30872 [No Abstract] [Full Text] [Related]
13. Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres. Wuerthele SM; Moore KE J Pharm Pharmacol; 1980 Jul; 32(7):507-10. PubMed ID: 6105192 [No Abstract] [Full Text] [Related]
14. Dopamine, noradrenaline and 3,4-dihydroxyphenylacetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline. Fekete MI; Herman JP; Kanyicska B; Palkovits M J Neural Transm; 1979; 45(3):207-18. PubMed ID: 479873 [TBL] [Abstract][Full Text] [Related]
15. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat. Nomura Y; Oki K; Segawa T J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536 [TBL] [Abstract][Full Text] [Related]
16. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata. Kamata K; Sugimoto A; Kameyama T Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872 [TBL] [Abstract][Full Text] [Related]
17. 3,4-Dihydroxyphenylacetic acid concentrations in the intermediate lobe and neural lobe of the posterior pituitary gland as an index of tuberohypophysial dopaminergic neuronal activity. Lindley SE; Gunnet JW; Lookingland KJ; Moore KE Brain Res; 1990 Jan; 506(1):133-8. PubMed ID: 2302550 [TBL] [Abstract][Full Text] [Related]
19. Contribution of noradrenergic neurons to 3,4-dihydroxyphenylacetic acid concentrations in the regions of the rat brain containing incertohypothalamic dopaminergic neurons. Tian Y; Lookingland KJ; Moore KE Brain Res; 1991 Jul; 555(1):135-40. PubMed ID: 1681993 [TBL] [Abstract][Full Text] [Related]
20. Effects of naloxone on d-amphetamine- and apomorphine-induced behavior. Hitzemann R; Curell J; Hom D; Loh H Neuropharmacology; 1982 Oct; 21(10):1005-11. PubMed ID: 6890635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]